Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathway. (Record no. 7612591)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01228 a2200313 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513034033.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199508s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1018-2438 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1159/000237013 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Drazen, J M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19950824 |
245 00 - TITLE STATEMENT | |
Title | Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathway. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | International archives of allergy and immunology |
Date of publication, distribution, etc. | |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 319-20 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adrenergic beta-Agonists |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Asthma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chronic Disease |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Forced Expiratory Volume |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hydroxyurea |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lipoxygenase Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Single-Blind Method |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Israel, E |
773 0# - HOST ITEM ENTRY | |
Title | International archives of allergy and immunology |
Related parts | vol. 107 |
-- | no. 1-3 |
-- | p. 319-20 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1159/000237013">https://doi.org/10.1159/000237013</a> |
Public note | Available from publisher's website |
No items available.